F

Fluidigm Corp
F:FLB

Watchlist Manager
Fluidigm Corp
F:FLB
Watchlist
Price: 1.89 EUR 0.53% Market Closed
Market Cap: 700.1m EUR
Have any thoughts about
Fluidigm Corp?
Write Note

Relative Value

The Relative Value of one FLB stock under the Base Case scenario is 1.16 EUR. Compared to the current market price of 1.89 EUR, Fluidigm Corp is Overvalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FLB Relative Value
Base Case
1.16 EUR
Overvaluation 39%
Relative Value
Price
F
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
15
vs Industry
Median 3Y
1.9
Median 5Y
2.2
Industry
4.1
Forward
4.2
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-4
Industry
32.7
Forward
-3.7
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-5.9
Industry
22.1
vs History
vs Industry
Median 3Y
-3.6
Median 5Y
-5.9
Industry
33.6
vs History
57
vs Industry
Median 3Y
1.2
Median 5Y
1.5
Industry
2.6
vs History
52
vs Industry
Median 3Y
1.5
Median 5Y
2.2
Industry
3.9
Forward
2.1
vs History
50
vs Industry
Median 3Y
3.3
Median 5Y
4.2
Industry
8.6
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-4.7
Industry
18.5
Forward
-4.2
vs History
vs Industry
Median 3Y
-2
Median 5Y
-3.4
Industry
23.7
Forward
-2.1
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-5.2
Industry
21.4
vs History
vs Industry
Median 3Y
-2
Median 5Y
-5
Industry
28.8
vs History
55
vs Industry
Median 3Y
0.7
Median 5Y
1.1
Industry
2.4

Multiples Across Competitors

FLB Competitors Multiples
Fluidigm Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Fluidigm Corp
F:FLB
699.9m EUR 4.7 -4.3 -3.5 -3
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 448.2 4 796.2 1 513.6 3 225.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.9B USD 4.7 32.7 21.2 30.4
US
Danaher Corp
NYSE:DHR
165.5B USD 7.8 42.5 26.7 40.2
KR
Samsung Biologics Co Ltd
KRX:207940
66.9T KRW 15.3 63.6 34.4 49.5
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.4B USD 5.9 29.8 22.2 25.9
US
IQVIA Holdings Inc
NYSE:IQV
36.2B USD 2.4 25.7 14.2 21.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD 7.1 33.6 24.1 26.9
US
West Pharmaceutical Services Inc
NYSE:WST
23.9B USD 8.3 47.8 32.1 40.3
CN
WuXi AppTec Co Ltd
SSE:603259
163.9B CNY 4.3 20.3 14.8 14.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
F
Fluidigm Corp
F:FLB
Average EV/EBITDA: 174.9
Negative Multiple: -3.5
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 513.6
23%
66.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.2
19%
1.1
US
Danaher Corp
NYSE:DHR
26.7
22%
1.2
KR
Samsung Biologics Co Ltd
KRX:207940
34.4
57%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
36%
1.2
US
Agilent Technologies Inc
NYSE:A
22.2
34%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
14.2
32%
0.4
US
Mettler-Toledo International Inc
NYSE:MTD
24.1
16%
1.5
US
West Pharmaceutical Services Inc
NYSE:WST
32.1
16%
2
CN
WuXi AppTec Co Ltd
SSE:603259
14.8
52%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
F
Fluidigm Corp
F:FLB
Average EV/EBIT: 352
Negative Multiple: -3
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
3 225.5
130%
24.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
30.4
57%
0.5
US
Danaher Corp
NYSE:DHR
40.2
59%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
49.5
76%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
37%
1.2
US
Agilent Technologies Inc
NYSE:A
25.9
42%
0.6
US
IQVIA Holdings Inc
NYSE:IQV
21.6
70%
0.3
US
Mettler-Toledo International Inc
NYSE:MTD
26.9
22%
1.2
US
West Pharmaceutical Services Inc
NYSE:WST
40.3
13%
3.2
CN
WuXi AppTec Co Ltd
SSE:603259
14.8
23%
0.6

See Also

Discover More
Back to Top